These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 8626783

  • 21. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity.
    Wang J, Sergina N, Ko TC, Gong J, Brattain MG.
    J Biol Chem; 2004 Sep 17; 279(38):40237-44. PubMed ID: 15271980
    [Abstract] [Full Text] [Related]

  • 22. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt.
    Ju EM, Choi KC, Hong SH, Lee CH, Kim BC, Kim SJ, Kim IH, Park SH.
    Biochem Biophys Res Commun; 2005 Mar 25; 328(4):1170-81. PubMed ID: 15708000
    [Abstract] [Full Text] [Related]

  • 23. TGF-beta1-mediated hypertrophy involves inhibiting pRB phosphorylation by blocking activation of cyclin E kinase.
    Liu B, Preisig P.
    Am J Physiol; 1999 Aug 25; 277(2):F186-94. PubMed ID: 10444572
    [Abstract] [Full Text] [Related]

  • 24. TGF-beta1 and HGF coordinately facilitate collagen turnover in subepithelial mesenchyme.
    Inoue T, Okada H, Kobayashi T, Watanabe Y, Kikuta T, Kanno Y, Takigawa M, Suzuki H.
    Biochem Biophys Res Commun; 2002 Sep 20; 297(2):255-60. PubMed ID: 12237111
    [Abstract] [Full Text] [Related]

  • 25. Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.
    Tsukada Y, Tanaka T, Miyazawa K, Kitamura N.
    J Biochem; 2004 Nov 20; 136(5):701-9. PubMed ID: 15632311
    [Abstract] [Full Text] [Related]

  • 26. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB.
    Kidney Int; 1997 Apr 20; 51(4):1228-36. PubMed ID: 9083291
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells.
    Satterwhite DJ, Aakre ME, Gorska AE, Moses HL.
    Cell Growth Differ; 1994 Aug 20; 5(8):789-99. PubMed ID: 7986745
    [Abstract] [Full Text] [Related]

  • 28. Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events.
    Laiho M, Rönnstrand L, Heino J, Decaprio JA, Ludlow JW, Livingston DM, Massagué J.
    Mol Cell Biol; 1991 Feb 20; 11(2):972-8. PubMed ID: 1990295
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of transforming growth factor on cell cycle regulatory molecules in human myeloid leukemia cells.
    Hu X, Zhang X, Zhong Q, Fisher AB, Bryington M, Zuckerman KS.
    Oncogene; 2001 Oct 18; 20(47):6840-50. PubMed ID: 11687963
    [Abstract] [Full Text] [Related]

  • 30. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ, Yan S, Herr KD, Wenner CE.
    Cancer Res; 1995 Apr 01; 55(7):1413-6. PubMed ID: 7882344
    [Abstract] [Full Text] [Related]

  • 31. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J, Ammanamanchi S, Ko TC, Brattain MG.
    Cancer Res; 2003 Jun 15; 63(12):3340-6. PubMed ID: 12810668
    [Abstract] [Full Text] [Related]

  • 32. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
    Miyazaki M, Ohashi R, Tsuji T, Mihara K, Gohda E, Namba M.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):873-80. PubMed ID: 9618305
    [Abstract] [Full Text] [Related]

  • 33. Hepatocyte growth Factor/Scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: comparison between the effects of HGF/SF and TGF-beta1 on fibronectin splicing at the EDA region.
    Inoue T, Nabeshima K, Shimao Y, Koono M.
    Biochem Biophys Res Commun; 1999 Jun 24; 260(1):225-31. PubMed ID: 10381371
    [Abstract] [Full Text] [Related]

  • 34. Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells.
    Choi KS, Eom YW, Kang Y, Ha MJ, Rhee H, Yoon JW, Kim SJ.
    J Biol Chem; 1999 Nov 05; 274(45):31775-83. PubMed ID: 10542199
    [Abstract] [Full Text] [Related]

  • 35. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
    Yamamoto H, Ueno H, Ooshima A, Takeshita A.
    J Biol Chem; 1996 Jul 05; 271(27):16253-9. PubMed ID: 8663151
    [Abstract] [Full Text] [Related]

  • 36. Hepatocyte growth factor stimulates DNA synthesis in alveolar epithelial type II cells in vitro.
    Shiratori M, Michalopoulos G, Shinozuka H, Singh G, Ogasawara H, Katyal SL.
    Am J Respir Cell Mol Biol; 1995 Feb 05; 12(2):171-80. PubMed ID: 7532419
    [Abstract] [Full Text] [Related]

  • 37. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC, Chen YQ.
    Oncogene; 1998 Sep 24; 17(12):1549-56. PubMed ID: 9794232
    [Abstract] [Full Text] [Related]

  • 38. Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4.
    Orend G, Huang W, Olayioye MA, Hynes NE, Chiquet-Ehrismann R.
    Oncogene; 2003 Jun 19; 22(25):3917-26. PubMed ID: 12813465
    [Abstract] [Full Text] [Related]

  • 39. Role of fibroblasts in HGF/SF-induced cohort migration of human colorectal carcinoma cells: fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-beta1.
    Shimao Y, Nabeshima K, Inoue T, Koono M.
    Int J Cancer; 1999 Jul 30; 82(3):449-58. PubMed ID: 10399964
    [Abstract] [Full Text] [Related]

  • 40. Transforming growth factor-beta-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines.
    Rich JN, Zhang M, Datto MB, Bigner DD, Wang XF.
    J Biol Chem; 1999 Dec 03; 274(49):35053-8. PubMed ID: 10574984
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.